NTPDase and 5'-nucleotidase activities from synaptosomes and platelets of rats exposed to cadmium and treated with N-acetylcysteine

International Journal of Developmental Neuroscience

Volumn 31, Issue 1, 2013, Pages 69-74

  Gonçalves, Jamile F ^a   Spanevello, Roselia M ^b   Fiorenza, Amanda M ^c   Mazzanti, Cinthia M ^c   Bagatini, Margarete D ^d   da Rosa, Cíntia S ^c   Becker, Lara V ^c   da Costa, Pauline ^c   Abdalla, Fátima H ^c   Morsch, Vera M ^c   Schetinger, Maria Rosa C ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Centro de Ciencias Químicas Farmacêuticas e de Alimentos Setor de Bioquímica   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^d UNIVERSIDADE FEDERAL DA FRONTEIRA SUL   (Brazil)

Author keywords

Cd; NAC; Purinergic system

Indexed keywords

5' NUCLEOTIDASE; ACETYLCYSTEINE; ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CADMIUM; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; NUCLEOTIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; HYDROLYSIS; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME; THROMBOCYTE;

5'-NUCLEOTIDASE; ACETYLCYSTEINE; ANALYSIS OF VARIANCE; ANIMALS; BLOOD PLATELETS; BRAIN; CADMIUM; FREE RADICAL SCAVENGERS; MALE; PYROPHOSPHATASES; RATS; RATS, WISTAR; SYNAPTOSOMES;

ANIMALIA; RATTUS;

EID: 84872393230     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.11.001     Document Type: Article

References (71)

1. Afonsi G., Russo I., Massuco P., Mattielo L., Cavalot F., Balbo A., Trovati M. Adenosine increases human platelet levels of cGMP through role in this antiaggregating effect. Thrombosis Research 2002, 105:71-78.
2. Bagatini M.D., Martins C.C., Battisti V., Spanevello R.M., Gasparetto D., Rosa C.S., Gonçalves J.F., Schetinger M.R.C., Santos R.B., Morsch V.M. Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction. Clinical Biochemistry 2008, 41:1181-1185.
3. Bilgen I., Oner G., Edremitlioglu M., Alkan Z., Cirrik S. Involvement of cholinoceptors in cadmium-induced endothelial dysfunction. Journal of Basic and Clinical Physiology and Pharmacology 2003, 14:55-76.
4. Birk A.V., Broekman J., Gladek E.M., Robertson H.D., Drosopoulos J.H.F., Marcus A.J., Szeto H. Role of a novel soluble nucleotide phosphohydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology. Journal of Laboratory and Clinical Medicine 2002, 139:116-124.
5. Birk A.V., Broekman J., Gladek E.M., Robertson H.D., Drosopoulos J.H.F., Marcus A.J., Szeto H. Role of extracellular ATP metabolism in regulation of platelet reactivity. Journal of Laboratory and Clinical Medicine 2002, 140:166-175.
6. Borges L.P., Brandão R., Godoi B., Nogueira C.W., Zeni G. Oral administration of diphenyl diselenide protects against cadmium-induced liver damage in rats. Chemico-Biological Interactions 2008, 171:15-25.
7. Borges V.C., Nogueira C.W. The role of thiol-reducing agents on modulation of glutamate binding induced by heavy metals in platelets. Toxicology In Vitro 2008, 22:438-443.
8. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:218-254.
9. Borowiec A., Lechward K., Tkacz-Stachowska K., Skladanowski A.C. Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases. Acta Biochimica Polonica 2006, 53:269-278.
10. Burnstock G. Historical review: ATP as a neurotransmitter. Trends in Pharmacological Sciences 2006, 27:166-176.
11. Caprino L., Togna G., Togna A.R. Cadmium-induced platelet hypersensitivity to aggregating agents. Pharmacological Research Communications 1979, 11:731-737.
12. 2+-ATPase activity. Analytical Biochemistry 1986, 157:375-378.
13. Colgan S.P., Eltzschig H.K., Eckle T. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signalling 2006, 2:351-360.
14. Cunha R.A. Adenosine as a neuromodulator and as homeostatic regulator in the nervous system: different role, different sources and different receptors. Neurochemistry International 2001, 38:107-125.
15. Cunha R.A., Ribeiro J.A. ATP as presynaptic modulator. Life Sciences 2000, 68:119-137.
16. Demontis M.P., Varoni M.V., Volpe A.R., Emanueli C., Madeddu P. Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium. British Journal of Pharmacology 1998, 123:129-135.
17. Dorn G.W. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes. Journal of Biological Chemistry 1990, 265:4240-4246.
18. Dumwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annual Review of Neuroscience 2001, 24:31-35.
19. El-Demerdash F.M., Yousef M.I., Kedwany F.S., Baghdadi H.H. Cadmium induced changes in lipid peroxidation, blood hematology, biochemical parameters and semen quality of male rats: protective role of vitamin E and β-carotene. Food and Chemical Toxicology 2004, 42:1563-1571.
20. Eum Ki-Do., Lee Mi-Sun., Paek D. Cadmium in blood and hypertension. Science of the Total Environment 2008, 407:147-153.
21. Feuvre R., Brough D., Rothwell N.A.T.P. Extracellular, P2X7 receptors in neurodegeneration. European Journal of Pharmacology 2002, 447:261-269.
22. Fields R.D., Bursnstock G. Purinergic signaling in neuron - glia interactions. Nature Review 2006, 7:423-436.
23. Fields R.D., Stevens B. ATP: an extracellular signaling molecule between neurons and glia. Trends in Neurosciences 2000, 23:625-633.
24. Glauser S.C., Bello C.T., Glauser E.M. Blood-cadmium level in normotensive and untreated hypertensive humans. Lancet 1976, 3:717-718.
25. Gonçalves J.F., Fiorenza A.M., Spanevello R.M., Mazzanti C.M., Bochi G.V., Antes F.G., Stefanello N., Rubin M.A., Dressler V.L., Morsch V.M., Schetinger M.R.C. N-acetylcysteine prevents memory deficits, the decrease in acetylcholinesterase activity and oxidative stress in rats exposed to cadmium. Chemico-Biological Interactions 2010, 186:53-60.
26. Gonçalves J.F., Duarte M.M.M.F., Fiorenza A.M., Spanevello R.M., Mazzanti C.M., Schmatz R., Bagatini M.D., Antes F.G., Costa P., Abdalla F.H., Dressler V.L., Morsch V.M., Schetinger M.R.C. Hematological indices and activity of NTPDase and cholinesterase enzymes in rats exposed to cadmium and treated with N-acetylcysteine. Biometals 2012, 25:1195-1206.
27. Gutiérrez-Reyes E.Y., Albores A., Ríos C. Increase of striatal dopamine release by cadmium in nursing rats and its prevention by dexamethasone-induced metallothionein. Toxicology 1998, 131:145-154.
28. Heymann D., Reddington M., Kreutzberg G.W. Subcellular localization of 5'-nucleotidase in rat brain. Journal of Neurochemistry 1984, 43:971-978.
29. Kaizer R.R., Maldonado P.A., Spanevello R.M., Corrêa M.C., Gonçalves J.F., Becker L.V., Morsch V.M., Schetinger M.R.C. The effect of aluminium on NTPDase and 5'-nucleotidase activities from rat synaptosomes and platelets. International Journal of Developmental Neuroscience 2007, 25:381-386.
30. Keating F., Whitaker D., Kabbani S., Ricci M., Sobel B., Schneider D. Relation of augment platelet reactivity to the magnitude of distribution of atherosclerosis. American Journal of Cardiology 2004, 94:725-728.
31. Kim K.R., Kim M.J., Rhee S.J. Effects of vitamin E on arachidonic acid cascade in platelets and aorta of acute cadmium-poisoned rats. Nutrition Research 2001, 21:657-665.
32. Kumar S.V., Bhattacharya S. In vitro toxicity of mercury, cadmium, and arsenic to platelet aggregation: influence of adenylate cyclase and phosphodiesterase activity. In Vitro & Molecular Toxicology 2000, 13:137-144.
33. Lunkes G., Lunkes D., Morsch V., Mazzanti C., Morsch A., Miron V., Schetinger M.R.C. NTPDase and 5'-nucleotidase in rats alloxan - induced diabetes. Diabetes Research and Clinical Practice 2004, 65:1-6.
34. Mazzanti C.M., Spanevello R.M., Morsch A., Zanin R., Battisti V., Ahmed M., Gonçalves J.F., Mazzanti A., Graça D.L., Morsch V.M., Schetinger M.R.C. Previous treatment with ebselen and vitamin E alters adenine nucleotide hydrolysis in platelets from adult rats experimentally demyelinated with ethidium bromide. Life Sciences 2007, 81:241-248.
35. Méndez-Armenta M., Ríos C. Cadmium neurotoxicity. Environmental Toxicology and Pharmacology 2007, 23:350-358.
36. Minami A., Takeda A., Nishibaba D., Takefuta S., Oku N. Cadmium toxicity in synaptic neurotransmission in the brain. Brain Research 2001, 894:336-339.
37. Mollaoglu H., Gokcimen A., Ozguner F., Oktem F., Koyu A., Kocak A., Demirin H., Gokalp O., Cicek E. Caffeic acid phenethyl ester prevents cadmium-induced cardiac impairment in rat. Toxicology 2006, 227:15-20.
38. Mukhopadhyay S., Mukhopadhyay S., Addya S., Bhattacharya D.K., Chatterjee G.C. Effects of cadmium treatment in vitro on the antioxidant protection mechanism and activation of human blood platelets. Thrombosis Research 1988, 50:419-427.
39. Nagy A., Delgado-Escueta A.V. Rapid preparation of synaptosomes from mammalian brain using non-toxic isosmotic gradient material (Percoll). Journal of Neurochemistry 1984, 43:1114-1123.
40. Nakagawa H., Nishijo M. Environmental cadmium exposure, hypertension and cardiovascular risk. Journal of Cardiovascular Risk 1996, 3:11-17.
41. Perry H.M., Erlanger M.W. Elevated circulating rennin activity in rats following doses of cadmium known to induce hypertension. Journal of Laboratory and Clinical Medicine 1973, 82:399-405.
42. Perry H.M., Erlanger M.W. Sodium retention in rats with cadmium-induced hypertension. Science of the Total Environment 1981, 22:31-38.
43. Pinho R.A., Silveira P.C.L., Silva L.A., Streck E.L., Dal-Pizzol F., Moreira J.C.F. N-acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. Environmental Research 2005, 99:355-360.
44. Pizent A., Jurasovic J., Telisman S. Blood pressure in relation to dietary calcium intake, alcohol consumption, blood lead, and blood cadmium in female nonsmokers. Journal of Trace Elements in Medicine and Biology 2001, 15:123-130.
45. Pilla C., Emanuelli T., Frasseto S.S., Battastini A.M.O., Dias R.D., Sarkis J.J.F. ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 1996, 7:225-230.
46. Remijin J.A., Wu Y., Jeninga E.H., Ijsseldijk J., Willigen G., Groot P., Sixma J., Nurden A., Nurden P. Role of ADP receptor P2y12 in platelet adhesion and thrombus formation in flowing blood. Arteriosclerosis, Thrombosis, and Vascular Biology 2002, 22:686-691.
47. Revis N. A possible mechanism for cadmium-induced hypertension in rats. Life Sciences 1977, 22:479-488.
48. Robson S.C., Sévigny J., Zimmermann H. The E-NTPDase family ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2006, 2:409-430.
49. Rozalski M., Nocun M., Watala C. Adenosine diphosphate receptors on blood platelets - potential new targets for antiplatelet therapy. Acta Biochimica Polonica 2005, 52:411-415.
50. Sadowska A.M., Manuel-y-Keenoy B., De Backer W.A. Antioxidant and antiinflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulmonary Pharmacology and Therapeutics 2007, 20:9-22.
51. Satarug S., Nishijo M., Ujjin P., Vanavanitkun Y., Moore M.R. Cadmium-induced nephropathy in the development of high blood pressure. Toxicology Letters 2005, 157:57-68.
52. Satarug S., Nishijo M., Lasker J.M., Edwards R.J., Moore M.R. Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases?. Tohoku Journal of Experimental Medicine 2006, 208:179-202.
53. Schmatz R., Schetinger M.R.C., Spanevello R.M., Mazzanti C.M., Stefanello N., Maldonado P.A., Gutierres J., Corrêa M.C., Girotto E., Moretto M.B., Morsch V.M. Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats. Life Sciences 2009, 84:345-350.
54. Schetinger M.R.C., Morsch V.M., Bonan C.D., Wyse A.T. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors 2007, 31:77-98.
55. Schetinger M.R.C., Porto N., Moretto M.B., Morsch V.M., Vieira V., Moro F., Neis R.T., Bittencourt S., Bonacorso H., Zanatta N. New benzodiazepines alter acetylcholinesterase and ATPDase activities. Neurochemical Research 2000, 25:949-955.
56. Sompamit K., Kukongviriyapan U., Donpunha W., Nakmareong S., Kukongviriyapan V. Reversal of cadmium-induced vascular dysfunction and oxidative stress by meso-2,3-dimercaptosuccinic acid in mice. Toxicology Letters 2010, 198:77-82.
57. Spanevello R.M., Mazzanti C.M., Kaizer R., Zanin R., Cargnelutti D., Hannel L., Corrêa M., Mazzanti A., Festugatto R., Graça D., Schetinger M.R.C., Morsch V.M. Apyrase and 5'-nucleotidase activities in synaptosomes from the cerebral cortex of rats experimentally demyelinated with ethidium bromide and treated with interferon-β. Neurochemical Research 2006, 31:455-462.
58. Spanevello R.M., Mazzanti C.M., Maldonado P.A., Zanin R., Morsch A., Hannel L., Mazzanti A., Festugatto R., Graça D., Schmatz R., Loro V.L., Schetinger M.R.C., Morsch V.M. Activities of enzymes that hydrolyze adenine nucleotides in platelets from rats experimentally demyelinated with ethidium bromide and treated with interferon-β. Life Sciences 2007, 80:1109-1114.
59. Spanevello R., Mazzanti C.M., Schmatz R., Bagatini M., Stefanello N., Correa M., Kaizer R., Maldonado P., Mazzanti A., Graça D.L., Martins T.B., Danesi C., Morsch V.M., Schetinger M.R.C. Effect of vitamin E on ectonucleotidase activities in synaptosomes and platelets and parameters of oxidative stress in rats experimentally demyelinated. Brain Research Bulletin 2009, 80:45-51.
60. Sperlágh B., Kittel A., Lajtha A., Vizi E.S. ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzymecytochemical evidence. Neuroscience 1995, 66:915-920.
61. Tellez-Plaza M., Navas-Acien A., Crainiceanu C.M., Guallar E. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environmental Health Perspectives 2008, 116:51-56.
62. Thun M.J., Osorio A.M., Schober S., Hannon W.M., Lewis B., Halperin W. Nephropathy in cadmium workers: assessment of risk from airborne occupational exposure to cadmium. British Journal of Industrial Medicine 1989, 46:689-697.
63. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Current Medicinal Chemistry 2005, 12:1161-1208.
64. Varoni M.V., Palomba D., Gianorso S., Anania V. Cadmium as an environmental factor of hypertension in animals: new perspectives on mechanisms. Veterinary Research Communications 2003, 27:807-810.
65. Viaene M., Masschelein R., Leeders J., De Groof M., Swerts L., Roels H. Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study. Occupational and Environmental Medicine 2000, 57:19-27.
66. Wagner D.D., Burger P. Platelets in inflammation and thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23:2131-2137.
67. Yoopan N., Wongsawatkul O., Watcharasit P., Piyachaturawat P., Satayavivad J. Contribution of cholinergic muscarinic functions in cadmium-induced hypertension in rats. Toxicology Letters 2006, 164:S155.
68. Yoopan N., Watcharasit P., Wongsawatkul O., Piyachaturawat P., Satayavivad J. Attenuation of eNOS expression in cadmium-induced hypertensive rats. Toxicology Letters 2008, 176:157-161.
69. Zalups R.K., Ahmad S. Molecular handling of cadmium in transporting epithelia. Toxicology and Applied Pharmacology 2003, 186:163-188.
70. Zimmermann H. Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis. Nature Medicine 1999, 9:987-988.
71. Zimmermann H. Ectonucleotidases: some recent developments and note on nomenclature. Drug Development Research 2001, 52:46-56.